Search research articles
Contact Us
Filters
Showing results (171-180 of 362) with videos related to
Page
of 37
Sort By:
ESMO Open
|
October 2, 2018
Report on the status of women occupying leadership roles in oncology
Eva Hofstädter-Thalmann, Urania Dafni, Tamara Allen, et al.
Nature Reviews. Clinical Oncology
|
August 27, 2024
Tumour mutational burden: clinical utility, challenges and emerging improvements
Jan Budczies, Daniel Kazdal, Michael Menzel, et al.
ESMO Open
|
October 2, 2018
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
Susana Banerjee, Urania Dafni, Tamara Allen, et al.
Nature Reviews. Clinical Oncology
|
July 24, 2023
Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challenges
Giannis Mountzios, Jordi Remon, Lizza E L Hendriks, et al.
ESMO Open
|
December 2, 2020
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians
Grace Chazan, Fanny Franchini, Marliese Alexander, et al.
Cancer Research
|
March 23, 2021
GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy
Pierre-Benoit Ancey, Caroline Contat, Gael Boivin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2020
Outcomes According to ALK Status Determined by Central Immunohistochemistry or Fluorescence In Situ Hybridization in Patients With ALK-Positive NSCLC Enrolled in the Phase 3 ALEX Study
Tony Mok, Solange Peters, D Ross Camidge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 7, 2024
Lung Cancer in Switzerland
Raphael Sven Werner, Alessandra Curioni-Fontecedro, Laetitia A Mauti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 8, 2018
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
Jeremy Lewin, Jean-Charles Soria, Anastasios Stathis, et al.
Medical Physics
|
May 13, 2020
Comparison of robust to standardized CT radiomics models to predict overall survival for non-small cell lung cancer patients
Diem Vuong, Marta Bogowicz, Sarah Denzler, et al.
Page
of 37
Search research articles
Search
Showing results (171-180 of 362) with videos related to
Sort By:
Page
of 37
ESMO Open
|
October 2, 2018
Report on the status of women occupying leadership roles in oncology
Eva Hofstädter-Thalmann, Urania Dafni, Tamara Allen, et al.
Nature Reviews. Clinical Oncology
|
August 27, 2024
Tumour mutational burden: clinical utility, challenges and emerging improvements
Jan Budczies, Daniel Kazdal, Michael Menzel, et al.
ESMO Open
|
October 2, 2018
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey
Susana Banerjee, Urania Dafni, Tamara Allen, et al.
Nature Reviews. Clinical Oncology
|
July 24, 2023
Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challenges
Giannis Mountzios, Jordi Remon, Lizza E L Hendriks, et al.
ESMO Open
|
December 2, 2020
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians
Grace Chazan, Fanny Franchini, Marliese Alexander, et al.
Cancer Research
|
March 23, 2021
GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy
Pierre-Benoit Ancey, Caroline Contat, Gael Boivin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2020
Outcomes According to ALK Status Determined by Central Immunohistochemistry or Fluorescence In Situ Hybridization in Patients With ALK-Positive NSCLC Enrolled in the Phase 3 ALEX Study
Tony Mok, Solange Peters, D Ross Camidge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 7, 2024
Lung Cancer in Switzerland
Raphael Sven Werner, Alessandra Curioni-Fontecedro, Laetitia A Mauti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 8, 2018
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
Jeremy Lewin, Jean-Charles Soria, Anastasios Stathis, et al.
Medical Physics
|
May 13, 2020
Comparison of robust to standardized CT radiomics models to predict overall survival for non-small cell lung cancer patients
Diem Vuong, Marta Bogowicz, Sarah Denzler, et al.
Page
of 37